The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline
Open Access
- 1 September 1987
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 92 (1) , 113-120
- https://doi.org/10.1111/j.1476-5381.1987.tb11302.x
Abstract
1 The responses to substance P, isoprenaline and noradrenaline were observed on human isolated coronary arteries removed from 30 human hearts, and were classified according to the age of the hearts, the presence or absence of cardiac failure and the degree of atherosclerosis. 2 The endothelium-dependent vasodilator, substance P (0.1 μm), relaxed rings precontracted with prostaglandin F2α, (PGF2α, 1 μm) when they were devoid of atherosclerosis. The presence of moderate or severe lesions of atherosclerosis abolished this response. There was no difference in the response, related to either the age of the hearts or to the presence or absence of cardiac failure. 3 The dose-response curves to isoprenaline (an endothelium-independent vasodilator) were also markedly altered by the presence of atherosclerotic lesions, while aging and the presence of cardiac failure did not alter the maximal relaxation. These last 2 factors induced only a rightward shift of the dose-response curves. 4 On severely atherosclerotic rings, β-adrenoceptor-mediated responses were so altered that the effect of noradrenaline was wholly vasoconstrictor (via α-adrenoceptors). This response was not modified after pretreatment with atenolol (10 μm). 5 It is concluded that atherosclerosis in human coronary arteries, induces alterations in the responses to substance P and to β-adrenoceptor agonists. The β-adrenoceptor-mediated relaxations seem more influenced by the presence of atherosclerosis than they are by aging or by the down-regulation induced by cardiac failure. Conversely, the α-adrenoceptor responses appear to be well preserved.This publication has 23 references indexed in Scilit:
- Comparison of the effect of beta adrenergic antagonists with different ancillary properties on isolated canine and human coronary arteriesCardiovascular Research, 1987
- Role of alpha-adrenergic coronary tone in exercise-induced angina pectorisThe American Journal of Cardiology, 1986
- Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise.Circulation, 1984
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries.Circulation, 1984
- Arrhythmogenic Effect of EpinephrineJournal of Cardiovascular Pharmacology, 1984
- Cardiac β-adrenoceptor modulation by amiodaroneBiochemical Pharmacology, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Comparison of the Immediate Effects of Five β-Adrenoreceptor-Blocking Drugs with Different Ancillary Properties in Angina PectorisNew England Journal of Medicine, 1979